Serum Anti-Malondialdehyde-Acetaldehyde IgA Antibody Concentration Improves Prediction of Coronary Atherosclerosis beyond Traditional Risk Factors in Patients with Rheumatoid Arthritis
Scientists measured serum concentrations of anti-malondialdehyde-acetaldehyde antibodies in 166 rheumatoid arthritis patients using ELISA cross-sectionally.